Kojin Therapeutics
USEntry
2021
Hold
4yr
Exit
2025
Who owns Kojin Therapeutics?
Kojin Therapeutics was owned by Cathay Capital through Cathay Health (2021 vintage) from 2021 to 2025. Across its history, Kojin Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Most recent investor
Cathay CapitalCathay Health · 2021 · Growth
2 ownership periods · full history below
Key facts
HQUnited States
SectorBiotech
Key takeaways
- ·Fully exited in 2025.
- ·Average hold across 2 realized cycles: 4 years.
Ownership history
2 ownership periods · co-invest detected
Exited
Last exited in 2025.
Co-invest · 2 holders · 2021 · 2025
More from Cathay Health
Other portfolio companies in the same fund.
FranceMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Kojin Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Kojin Therapeutics?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Kojin Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue